In patients with hypercholesterolemia, PTX3 correlated with the severity of vascular disease and statin therapy decreased plasma PTX3 levels, which suggests an involvement of PTX3 in vascular inflammation triggered by LDL‐C (Ohbayashi et al., 2009). Here, PTX3 is linked to Hypercholesterolemia.